Breztri Aerosphere 160 micrograms Pressurised inhalation, suspension
PDF Leaflet Revision Date: 21 October 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Maintenance treatment for COPD.
Dosage (summary)
2 inhalations twice daily.
Onset of Action / Duration
Onset: hours, Duration: 12 hours
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Use only if benefits outweigh risks; minimal transfer to breast milk.
Key Drug Interactions
- CYP3A4 inhibitors
- Beta-adrenergic blockers
Contraindications
- Hypersensitivity to components
Common side effects
- Oral candidiasis
- Pneumonia
- Hyperglycaemia
- Anxiety
- Palpitations
Counselling Points
- Instruct on proper inhalation technique
- Do not double dose if missed
- Monitor for worsening symptoms
Serious warnings
- Paradoxical bronchospasm
- Not for acute use
- Potential for pneumonia
Important Disclaimer
The Breztri Aerosphere 160 micrograms Pressurised inhalation, suspension professional information leaflet below is the property of Astrazeneca Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
